A new minimally invasive treatment for overactive bladder
Clinical readiness of Uzap - the minimally invasive Overactive Bladder treatment
This study is testing a new device called the NewUro Uzap, which provides a quick and gentle treatment for people with overactive bladder to help reduce the urge to urinate and improve their daily life, all without needing medications or surgery.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stellartech Research Corporation NIH-funded |
| Lab location | 1 site (Milpitas, United States) |
| Project ID | NIH-10874601 on NIH RePORTER |
What this research studies
This research focuses on developing the NewUro Uzap device, which offers a minimally invasive, single-session treatment for overactive bladder (OAB). The Uzap device uses transurethral radiofrequency mucosal partitioning to alleviate symptoms without the need for drugs or implants. By targeting excessive electrical connectivity in the bladder mucosa, the device aims to reduce the frequency of urges to urinate and improve overall bladder function. Patients will be monitored for outcomes related to symptom relief and quality of life improvements.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who experience symptoms of overactive bladder.
Not a fit: Patients with other underlying bladder conditions or those who are not responsive to minimally invasive treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a long-lasting, effective treatment option for patients suffering from overactive bladder.
How similar studies have performed: Previous research has shown promise with similar minimally invasive approaches, indicating potential for success with the Uzap device.
Where this research is happening
Milpitas, United States
- Stellartech Research Corporation — Milpitas, United States (Active)
Researchers
- Principal investigator: Stern, Roger — Stellartech Research Corporation
- Study coordinator: Stern, Roger
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.